China Health Technology Group (01069.HK) plans to issue rights shares on a "1 for 2" basis, raising up to HKD 51.5 million.

robot
Abstract generation in progress

Gelonghui March 27丨China Health Technology Group (01069.HK) announced that the company plans to issue up to 206 million shares of rights issue shares on a basis of “1 for 2.” The subscription price is HK$0.25 per share, representing a discount of approximately 20.63% compared with the closing price of HK$0.315 per share reported on the Hong Kong Stock Exchange on the last trading day. The gross proceeds from the offering will amount to up to approximately HK$51.50 million (assuming the rights issue is fully subscribed).

The company plans to use the net proceeds from the rights issue for (i) approximately 44.00% to acquire ginseng plantation land and conduct related market promotion and publicity activities, to support the expansion of the Group’s ginseng plantation business; (ii) approximately 36.00% to invest in the medical aesthetics industry; and (iii) approximately 20.00% as general working capital for the Group.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin